← FDA DRUG APPROVALS

FDA ANDA · ANDA078698

FLUCONAZOLE

Sponsor: HIKMA FARMACEUTICA

APPLICATION
ANDA078698
TYPE
ANDA
ORIGINAL APPROVAL
2012-01-30
LATEST ACTION
2025-04-25
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERPrescription
FLUCONAZOLE 200MG/100ML (2MG/ML) · INJECTABLE · INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERPrescription
FLUCONAZOLE 400MG/200ML (2MG/ML) · INJECTABLE · INJECTION

Approval history

2025-04-25Labeling · Supplement 10 · standardAP
2025-04-25Labeling · Supplement 9 · standardAP
2025-04-25Labeling · Supplement 7 · standardAP
2025-04-25Labeling · Supplement 5 · standardAP
2015-03-19Labeling · Supplement 4 · standardAP
2012-01-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →